Back to search

University of Ioannina

Ο ρόλος των κλασικών και νεότερων παραγόντων κινδύνου στην ανάπτυξη, έκταση και τρόπο εμφάνισης της στεφανιαίας νόσου

Abstract

dc:description

Background – Aim. Cardiovascular diseases are the leading cause of death in the western world. Atherosclerosis, the pathological substrate of cardiovascular events, is mainly an inflammatory process that begins with endothelial dysfunction. A variety of factors have been shown to contribute to the pathogenesis of atherosclerosis, and are related to cardiovascular evaluation and prognosis. The presence of type 2 diabetes increases the overall cardiovascular risk up to five times and is often considered as an equivalent to coronary heart disease. It is characterized by hyperglycemia and inflammation but simultaneously coexists with a number of comorbidities leading to even greater risk. Nevertheless, 1/3 to 1/2 of the cardiovascular events are not related to the presence of diabetes or to any other traditional risk factor. Meanwhile, there is a significant number of patients with high-risk characteristics who do not develop coronary heart disease or may have an excellent prognosis after cardiovascular events. Recently, meticulous research has been undertaken, in order to better understand the role of inflammation and its molecular mediators. It seems that the role of various inflammatory pathways in the pathogenesis of atherosclerosis is pivotal, but their final impact is at least partly determined by genetic factors. So far, at least 20 genes have been linked with coronary artery disease. Most of them are related to lipid regulation, but there is still uncertainty about their role in inflammation. Single gene variants (SNPs), related to inflammation and the simultaneous regulation of oxidized phospholipids and lipoproteins, are a promising and evolving field of research. Their influence on traditional and emerging atherosclerotic risk factors may be the key to the atherosclerotic process and coronary heart disease in general.The extent of coronary artery disease is determined using special angiographic scoring systems. Nevertheless, coronary angiography is an accurate but invasive and expensive method for the diagnosis of coronary heart disease. Attempts have been made to detect markers that could possibly predict the presence and extent of coronary lesions. Traditional risk factors cannot predict the presence and extent of coronary atherosclerosis especially in patients that present with acute coronary syndromes. Inflammation genes could potentially positively or negatively affect the prognostic value of specific molecules.Prognosis of the patients who undertake coronary angiography is an even greater challenge. A correct estimation of low probability of significant or extensive CAD may reduce the need for heart catheterizations, and alternatively lead to drug treatment. It is therefore important to find new, reliable and easily measurable biomarkers that could predict the degree of coronary artery disease and the possibility of future cardiovascular events. Selectively incorporating them into multifactorial prediction models may help to identify individuals under high risk of CVD, prevent unnecessary catheterizations, and improve prevention strategies.The aims of the present study were: 1. The identification of demographic, clinical, laboratory, genetic or angiographic characteristics that may determine the clinical expression of coronary heart disease. 2. The comparison of traditional, emerging and under study risk factors between patients who present with acute or stable coronary artery disease. Additionally, the detection of prognostic markers for the clinical expression and extent of CAD, as well as the consequent establishment of prognostic multifactorial models. Moreover, the clarification of the role and impact on other factors of diabetes mellitus. Finally, the impact of six certain gene polymorphisms of IL-1 regarding the predictability of several risk factors and mostly of the inflammatory ones. 3. The comparison of angiographic extent between stable and unstable coronary artery disease and the identification of prognostic markers. The importance of symptoms in the final presence of a significant disease in patients with stable coronary artery disease was an additional field of research. 4. The identification of new prognostic markers for future cardiovascular events (MACES). At the same time, we sought to investigate how polymorphisms (SNPs) related to IL-1 gene affect the prognostic factors. Finally, the equivalence of diabetes with coronary artery disease regarding MACES was questioned. Materials - Methods. The study included 1104 patients who underwent coronary angiography due to suspected coronary heart disease (stable and unstable angina, acute myocardial infarction, asymptomatic with positive non-invasive ischemia tests). Those with a history of previous revascularization and/or aortic valve stenosis were excluded. Symptoms, demographics, lifestyle and family history were recorded for all participants. Somatometric parameters and blood pressure were evaluated before invasion. Blood samples taken during coronary angiography were immediately analyzed for common biochemical markers (e.g. Glc, Ur, Cr, UA, HbA1c, LDL, HDL, TRG) as well as inflammatory ones (hsCRP). Body mass index and glomerular filtration rate were also calculated. After special processing blood samples were analyzed in the USA for oxPLs and Lp(a) levels as well as the presence of six gene polymorphisms of IL-1a and IL-1b. Of those, IL1A (+4845) rs1756, IL1B (+3954) rs1143634 and IL1B (-511) rs16944 were studied, and the combinations associated with higher IL-1α, β were defined as positive genotype. Finally, for each patient, coronary angiography was assessed with seven scores, but only the Gensini and SYNTAX scores were finally chosen. Offline quantitative coronary analysis (QCA) was vastly used to assess atherosclerotic lesions. All participants were divided into two groups, those with stable (N= 854) or unstable (N= 250) coronary artery disease. Those were further divided into diabetic and non-diabetic. For each subgroup, ie SCAD-DM (N= 390), SCAD-nonDM (N= 464), ACS-DM (N= 102), ACS-nonDM (N= 148) a comparison was made regarding all the above factors. The comparison also concerned the influence of the genotype on prognostic factors in patients with stable and unstable disease. The inflammatory molecules and angiographic scores were stratified according to their concentration. For better evaluation and determination of possible interactions, additional groups were made based on the mean value and the presence or absence of the genotype. Finally, death from any cause, cardiovascular death, stroke, the need for revascularization, and the occurrence of an acute coronary event, were defined as major adverse cardiovascular events (MACES). A follow-up was undertaken for the majority of patients at 48 and at 60 months after the coronary angiography. The follow-up was successfully completed for 81,1% of the patients and 11% of them presented MACES. Stroke was the commonest one. For those who developed MACES, prognostic factors were thoroughly reviewed and new grouping was performed to investigate the alleged equivalence of coronary heart disease and diabetes.Results: First sub-study. The patients referred for coronary angiography are primarily men, about 65,2 (±10,99) years, current smokers (37,5%) and overweight/obese (80,5%). Dyslipidemia and hypertension were recorded in 82% and 77% of the population respectively. About half of them are diabetic (44,6%), 35,6% have a family history of coronary heart disease, and only 22,3% have a known coronary artery disease. Finally, they have high levels of inflammation and satisfactory renal function.Second sub-study. Patients with SCAD have worse cardiovascular profile compared to ACS patients. In particular, they are more likely to have high blood pressure (78%) and dyslipidemia (89%). In contrast, instability is not associated with traditional cardiovascular risk factors, but with a history of coronary heart disease (35,2%) and elevated glucose levels. Regarding the inflammatory markers, ACS patients show the highest levels of hsCRP and Lp(a), while the SCAD patients have higher oxPLS, a marker of mixed inflammatory and fatty acids disorder. Regarding the angiographic extent of coronary heart disease, patients with ACS not only rarely have normal coronary arteries, but also present a more extensive angiographic disease. Men and smokers are no longer at risk of developing a specific form of CHD. Similarly, the presence of diabetes does not predispose to stable or unstable coronary artery disease. Nevertheless, diabetic stable coronary patients have some distinct features compared to non-diabetics; they are older, have a higher body mass index, with worse renal function, dyslipidemia, hypertension, and receive treatment more frequently. Diabetes mellitus is accompanied worse glycemic and lipid profile, ie higher glucose, HbA1c, triglycerides and Lp (a) values, and lower HDL. Cardiovascular risk scores (FRS) as well as inflammation (hsCRP, Lp (a)) are also clearly higher. The extent of coronary heart disease is greater compared to non-diabetics by any means.Factors that can independently predict the onset of stable coronary heart disease in diabetic patients are male gender, smoking, hypertension, good renal function and elevated glucose levels. HsCRP, as an inflammatory marker, leads the diabetic to stable disease, only at levels of > 4mg/l. The established prognostic model, that includes the above factors, predict the occurrence of stable disease by 73.5% in this population. Non-diabetic patients are more likely to develop stable coronary heart disease if they are male, have dyslipidemia, impaired renal function or even higher markers of inflammation (hsCRP> 9mg/l). In this population the existence typical symptoms, in contrast to diabetics, seems to adequately predict the presence of SCAD. No known model predicts stable disease in non-diabetics other than the one we developed, which has a 71% power. The positive genotype does not affect the action and prognostication of oxPLs and Lp(a), yet it affects significantly hsCRP in both diabetic and non-diabetic patients alike. The prognostic power of very high oxPLs (> 15.5mg/dl) is seen in young non-diabetics and is considered indistinct, whereas the genotype increases five times the risk of SCAD. Thus, in the presence of severe inflammation (hsCRP> 9mg/l) the genotype coexistence increases the probability of SCAD by eight times in diabetics and by 11 times in non-diabetics. Especially for older diabetics, the burden of its absence also reaches 11 times. Thus, the genotype has a strong protective role for all patients under intense inflammation, for the presence of stable coronary heart disease. Indicators that predict the onset of unstable coronary heart disease are male gender, advanced age and high inflammatory markers (hsCRP≥10mg/l). The known history of coronary heart disease is also aggravating. The above do not differ either in the presence or absence of diabetes, with the exception of diabetics where glucose is also predictive. Severe inflammation has a higher prognostic value in non-diabetics. In severe inflammation with high hsCRP (≥10mg/l), the absence of the genotype is a very strong prognostic indicator of the occurrence of acute coronary event in the whole population, multiplying by 22 this probability.Third sub-study. About half of the patients who underwent coronary angiography had normal blood vessels. Atherosclerosis is more extensive in patients with unstable compared to stable coronary artery disease. Factors that predict disease extent in ACS patients are male gender, advanced age and hsCRP. The same markers appear either using the Gensini or the SYNTAX score, with the latter highlighting the role of dyslipidemia too. Assessment of angiographic extent in SCAD patients through Gensini score, showed that moderate disease can be predicted by male gender and hsCRP. Severely extensive disease is more probable between men, smokers and patients with hypertension, dyslipidemia, impaired renal function or severe inflammation (hsCRP, Lp(a)). Similarly using the SYNTAX score, those who are men or present immense inflammation have an increased chance of both moderate and high extent of CAD. However, smoking (moderate extent), dyslipidemia and diabetes mellitus acquire a strong prognostic role for this score, especially for extensive disease. Additionally, diabetes mellitus gets a pivotal prognostic role only if patients with normal coronary angiography are excluded, predicting by 60% the extensive disease. The same goes for age and impaired kidney function. In the same substudy, high Lp(a) values appear prognostic, while hsCRP loses its significance. HsCRP remains prognostic only if Lp(a) is not taken into account. The prognostic power of Lp(a) is maintained when the genotype is present, but its absence triples the probability of severe disease, particularly when Lp(a) is high. HsCRP is not recommended as a prognostic marker of CAD extent, as the results are contradictory. The genotype only slightly enhances its predictability.Non-diabetic SCAD patients do not differ much from the general SCAD population, as they are more likely to have extensive disease when they are men, advanced in age, with impaired renal function and severe inflammation (hsCRP, Lp(a)). For the moderate disease, increased oxPLs are also predictive, posing a X2.5 greater risk. Diabetic SCAD patients are more likely to develop extensive coronary artery disease when they are men, hypertensive, with elevated glucose or hsCRP levels. The UKPDS prognostic tool aptly predicts the extensive disease. HbA1c is independent predictive marker for SYNTAX but not for Gensini score. Smoking and normal kidney function primarily predict moderate disease. Also, very high Lp(a) concentration foresees the severely extensive disease, omitting those with normal coronary arteries. As in the general SCAD population, genotype does not affect the prognostic power of hsCRP in non-diabetics, while its effects are contradictory enhancing the predictability of oxPLs if present, and of Lp(a) if absent. Similarly, the genotype makes very high oxPLs more predictive for CAD extent, concerning diabetic SCAD patients. On the contrary, positive genotype deprives the predictability of hsCRP for severe disease, in the same subgroup. Regarding symptoms, non-diabetics with typical symptoms have 30% probability of at least moderate angiographic disease, while diabetics reach 45%.Fourth sub-study. Major adverse cardiovascular events (MACES) occur in 11-12% of patients undergoing coronary angiography. The most common is stroke, especially in stable coronary artery disease patients (SCAD). Advanced age and the genotype predispose to MACES after an acute coronary event (ACS). For this subpopulation the genotype triples the risk and each year by 7%. A non-independent but important indicator is the history of coronary heart disease. Additionally, after catheterization, ACS subjects present steadily more MACES compared to SCAD, reaching a 20% incidence in 48 months. On the other hand, advanced age, hypertension and elevated Lp(a) are MACES predictors for the SCAD subgroup. In cases of increased Lp(a), the genotype doubles its prognostic power. Hypertension is the strongest predictor, as it increases the risk by 3.6 times. At 48 months of follow up, 15% of hypertensive patients will relapse. Not independent markers are the extensive coronary atherosclerosis and the history of CAD, presenting 1.6 times greater risk. For the non-diabetic ones, age, hypertension, elevated Lp(a) and smoking are independent predictors of MACES, while the extent of lesions, the history of CAD and elevated HbA1c are marginally significant. The predictors for diabetics are almost identical, including advanced age and hypertension, but hsCRP seems to yield a similar significance too. In line with the above, 13% of SCAD diabetics with hypertension will experience a recurrence at 48 months. In fact, hypertensive SCAD patients with diabetes (DM) will develop MACES sooner (<24 months), whilst neither diabetes nor smoking per se are predictive. Early events in SCAD-DM patients are also predicted by elevated hsCRP and normal renal function. Non-diabetic (nonDM-SCAD) patients who are elderly, with arterial hypertension, history of CAD or extensive disease, will present MACES sooner too (<24 months). Hyperglycemia and inflammation (hsCRP) for this subgroup appear to be marginally predictive. Finally, regardless of the presence of diabetes, patients with significant coronary artery disease (>50%), seem to relapse more frequently and in a shorter period of time. Moreover, diabetes per se is not associated with greater incidence or early MACES. CAD-DM compared to CAD-nonDM subjects seem to experience more MACES at 24 but not at 48 months of follow-up. Thus, diabetes does not play a pivotal role for the recurrence of heart disease and is not its equivalent. Nevertheless, 9% of diabetics, despite the absence of significant coronary heart disease, tend to have MACES but no related predictive markers were found.Conclusions. Stable coronary artery disease (SCAD) is characterized by adverse cardiovascular risk profile, including traditional markers such as hypertension and dyslipidemia. Among the emerging markers, it is strongly associated with oxPLs, a molecule of inflammatory and lipid origin. Diabetic patients with SCAD often present the features of the metabolic syndrome (obesity, hypertension, dyslipidemia, hyperglycemia), higher Framingham Risk Score, as well as novel inflammatory markers (hsCRP, Lp(a)). Contrary to SCAD, acute coronary syndrome (ACS) is not associated with established cardiovascular risk factors, but primarily with inflammation, expressed as hsCRP and Lp(a), hyperglycemia and pre-existing coronary heart disease. Male gender, advanced age, history of CAD, and hyperglycemia mainly for diabetics, are independent prognostic factors for ACS presentation. Moreover, severe inflammation (hsCRP≥10mg/l) is prognostic primarily for non-diabetics. While, diabetes mellitus per se plays no predictive role, among diabetics, those who are men, smokers, hypertensives, with at least moderate renal function but poor glycemic control, are prone to SCAD. Conversely, diabetics with advanced age, history of CAD, and those who present with acute hyperglycemia and severe inflammation (hsCRP≥10mg/l) have a tendency to develop ACS. Non-diabetic patients undergoing coronary angiography are more likely to present with SCAD when referring to male gender, dyslipidemia, impaired renal function, severe inflammation (hsCRP≥10mg/l) and typical symptoms. Acute coronary syndromes are characterized by more extensive coronary artery disease. Specifically, male gender, advanced age and severe inflammation predispose to greater extent. Among SCAD subjects, males, elderly, smokers and those with hypertension, dyslipidemia, impaired renal function and severe inflammation (hsCRP, Lp(a)) present often extensive coronary atherosclerosis. Diabetic subjects have 60% probability of developing greater lesions, among stable coronary patients, compared to normoglycemic ones. Male gender, hypertension, hyperglycemia, smoking, normal renal function, high UKPDS risk score and intense inflammation (hsCRP, Lp(a)) predispose to extensive disease for SCAD diabetics. The presence of typical angina strongly predicts the significant coronary artery disease in diabetic patients.Under conditions of intense inflammation (hsCRP≥10mg/l), the genotype is highly protective against coronary artery disease development. Its role is even more pivotal in ACS. Its relation to hsCRP is direct and not affected by the presence of diabetes. On the contrary, its effect on oxPLs and Lp(a) levels and predictive power is inconsistent. The genotype cannot predict the extent of coronary atherosclerotic disease. Even more, is obscures the prognostication of hsCRP levels on CAD extent; therefore, is not a recommended marker. Finally, it appears to be counteractive against the detrimental effects of Lp(a) regarding coronary atherosclerosis in SCAD patients. The most common major adverse cardiovascular event (MACE) among those undergoing coronary angiography is stroke. It usually affects SCAD diabetic patients. MACES after an ACS episode can be predicted by advanced age, history of CAD, and the presence of the genotype which triples the risk. In SCAD cases the strongest prognostic MACES marker is hypertension followed by age and elevated Lp(a). Lp(a) is prognostically enhanced by the presence of the genotype. The history of CAD and the extensive atherosclerosis predispose to MACES, but not independently. Diabetic status only adds hsCRP as a prognostic indicator. Howbeit, diabetes per se cannot predict MACES. Of note is that diabetes mellitus amplifies the effects of hypertension, which is the strongest prognostic factor, leading sooner to MACES (<24 months). In the sub-group DM-SCAD subjects, short-term MACES are predicted by the presence of severe inflammation and normal renal function. Advanced age, hypertension, extensive disease and history of CAD lead rapidly to new events in nonDM-SCAD patients. Not only the extensive atherosclerosis, but also the presence of significance CAD is adequate for the occurrence of MACES in a shorter time. Finally, according to our findings, diabetes mellitus is not equivalent to atherosclerotic cardiovascular disease.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Marini, Aikaterini
  • Μαρίνη, Αικατερίνη

Subjects

dc:subject × 21

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/53976

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Marini, Aikaterini; Μαρίνη, Αικατερίνη. Ο ρόλος των κλασικών και νεότερων παραγόντων κινδύνου στην ανάπτυξη, έκταση και τρόπο εμφάνισης της στεφανιαίας νόσου. University of Ioannina, 2023. http://hdl.handle.net/10442/hedi/53976